logo
Select company
Select metric
$ -123.57MConsolidated Income
VS
Market
10
Sector
18
Industry
24
History
57
$ 6.47Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information

Ticker

KPTI

Company Name

KARYOPHARM THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KARYOPHARM THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KPTI - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -123.57M
3/31/2025$ -62.52M
12/31/2024$ -76.42M
9/30/2024$ -87.48M
6/30/2024$ -89.91M
3/31/2024$ -146.34M
12/31/2023$ -143.1M
9/30/2023$ -139.77M
6/30/2023$ -141.59M
3/31/2023$ -158.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -201.5M.
  • Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average Cons. Inc. has been $ -138.52M.
  • The median Cons. Inc. for KARYOPHARM THERAPEUTICS INC during this period was $ -140.68M
  • KARYOPHARM THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -62.52M.
  • The lowest Cons. Inc. recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe $ -207.91M

KARYOPHARM THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
IPSC : CENTURY THERAPEUTICS INC $ -23.28MMRSN : MERSANA THERAPEUTICS INC $ -74.04MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -169.76MIGC : IGC PHARMA INC $ -6.34MXLO : XILIO THERAPEUTICS INC $ -56.22MALXO : ALX ONCOLOGY HOLDINGS INC $ -116.57MGBIO : GENERATION BIO CO $ -72.42MCLSD : CLEARSIDE BIOMEDICAL INC $ -27.71MTAOX : TAO SYNERGIES INC $ -31.38MESLA : ESTRELLA IMMUNOPHARMA INC $ -12.08M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

KPTI - Consolidated Income, Last 5 years

$ -207.91M

Minimum

Jun 30, 2021

$ -62.52M

Maximum

Mar 31, 2025

$ -138.52M

Average

$ -140.68M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M